# Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

> **NCT01974284** · NA · TERMINATED · sponsor: **Yale University** · enrollment: 7 (actual)

## Conditions studied

- Papillary Thyroid Cancer

## Interventions

- **DRUG:** percutaneous ethanol ablation

## Key facts

- **NCT ID:** NCT01974284
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-06-29
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of patient enrollment
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974284, "Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01974284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*